Adagene (ADAG) Earnings Date & Reports

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ADAG is expected to report earnings to rise 10.34% to -31 cents per share on August 27

Q2'25

Est.

$-0.32

Q4'24

Beat

by $0.18

Q2'24

Missed

by $0.03

Q4'23

Beat

by $0.96

Q3'23

Missed

by $0.04

The last earnings report on March 24 showed earnings per share of -28 cents, beating the estimate of -46 cents. With 12.32K shares outstanding, the current market capitalization sits at 72.08M.

View a ticker or compare two or three

Compare

ADAG